Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06193109
Status:
COMPLETED
Last Update Posted:
2024-01-05
First Post:
2023-12-12
Brief Title:
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
Sponsor:
Burapha University
Organization:
Burapha University
Study Overview
Official Title:
The Prognostic Impact of Right Ventricular Systolic Dysfunction on the Survival of Patients With Sepsis and Septic Shock
Status:
COMPLETED
Status Verified Date:
2023-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study sought to evaluate the association of right ventricular systolic dysfunction and 28-day in-hospital mortality in patients with sepsis and septic shock Prospective cohort study of adult patients admitted at Burapha university hospital from October 1 2022 through June 30 2023 for sepsis and septic shock who had an echocardiogram within 72 hours after admission for evaluating right ventricular systolic function Right ventricular systolic dysfunction was defned by the American Society of Echocardiography criteria Outcomes included 28-day in-hospital mortality maximal blood lactate length of intensive care unitICU stay and duration of mechanical ventilation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None